API Technology Transfer
Midas Pharma offers complete end-to-end solutions for a technology transfer based on different models of co-operation, license and supply. Each project set-up is unique, based on the project targets and thorough analysis of available know-how.
Following consultation with in-house experts and in close cooperation with you, we provide tailor-made solutions for your particular expectations of the targeted transfer.
We offer a range of models covering e.g. the transfer of process and analytical know-how for an API (or IM-Intermediate) at any stage of the substance lifecycle (lab, pilot, commercial phase).
The transfer can be carried out for you on an exclusive basis (e.g. outsourcing/ site transfer) as a contract development and/or contract manufacture based on your needs.
Alternatively, Midas is also interested in licensing-in technologies from partners, e.g. in case of:
- a hard exit - discontinuation of production, site closure at your end, or
- a soft exit - models which include covering your captive demands at favorable conditions
In case of a licensing-in, the investments for implementation, validation, registration, and manufacture are fully borne by Midas. You benefit at no risk!
Your benefits of partnering:
- Various business models based on your needs and project targets
- Diligent project management by in-house experts
- High grade of flexibility (chemistry type, scale, engineering solutions, access to worldwide laboratory & production units)
- Use of special technologies & broad spectrum of chemical expertise via our pool of trusted partners (CROs and CMOs)
- In-house expertise to cover all IP, regulatory, quality, logistics aspects
- Network of qualified suppliers for sourcing of basic chemicals, starting materials, reagents, intermediates (non-GMP and GMP)
- Strong in-house marketing & sales task force
- Proven Track record of over 30 years of experience in pharma
Your Contact
Dr. Gordana Gadanji
Custom Synthesis & Technology Transfer
Director
Rheinstr. 49
55218 Ingelheim
Germany
Discover our products
Midas offers intermediates, drug substances and drug products, as well as licensing opportunities of drug product developments